PAS
SYNH

Park Avenue Securities’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Park Avenue Securities’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,263
Closed -$266K – 1206
2022
Q4 		$266K Sell
7,263
-3,928
-35% -$155K ﹤0.01% 1025
2022
Q3 		$528K Sell
11,191
-2,030
-15% -$131K 0.01% 690
2022
Q2 		$948K Buy
13,221
+1,207
+10% +$88.2K 0.02% 486
2022
Q1 		$972K Buy
12,014
+18
+0.2% +$1.52K 0.02% 493
2021
Q4 		$1.23M Buy
11,996
+791
+7% +$76K 0.02% 394
2021
Q3 		$980K Buy
11,205
+851
+8% +$77K 0.02% 422
2021
Q2 		$927K Buy
10,354
+726
+8% +$61.3K 0.02% 421
2021
Q1 		$730K Buy
9,628
+3,006
+45% +$227K 0.02% 468
2020
Q4 		$451K Buy
6,622
+1,474
+29% +$91.9K 0.01% 536
2020
Q3 		$274K Buy
5,148
+1,554
+43% +$92.5K 0.01% 605
2020
Q2 		$209K Buy
+3,594
New +$193K 0.01% 632

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Park Avenue Securities's SYNH Position: Q1 2023 in Review

Park Avenue Securities sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 7,263 shares — an estimated $266K sold.

Park Avenue Securities first reported a position in SYNH in Q2 2020 and held it in 11 quarters. The position peaked at $1.23M in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Park Avenue Securities reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Park Avenue Securities sold 7,263 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $266K.
  • Park Avenue Securities first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 11 quarters.
  • Park Avenue Securities's Syneos Health, Inc. Class A Common Stock position peaked at $1.23M in Q4 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Park Avenue Securities's 13F filing for Q1 2023, filed 18 Apr 2023.